Synapse - Jae Park

Results (378)

A first-in-human phase 1, multicenter, open-label study of CB-012, a next-generation CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy for adults with relapsed/refractory acute myeloid leukemia (AMpLify)

Meeting Abstract

Daver, N. G.; Maiti, A.; Sallman, D. A.; Roboz, G. J.; Solh, M. M.; Milano, F.; Strickland, S. A.; Eghtedar, A.; Kanner, S. B.; Ledergor, G.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Dermatologic adverse events following CD19-directed CAR T-cell therapy in hematologic malignancies

Meeting Abstract

Storgard, R.; Reingold, R.; Parisi, R.; Dusza, S.; Noor, S.; Park, J.; Sauter, C.; Curran, K.; Perales, M.; Scordo, M.; more...
Journal of the American Academy of Dermatology (2024)

Fulltext@MSK | Save

Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: Lymphoid neoplasms

Correspondence

Grever, M.; Andritsos, L.; Anghelina, M.; Arons, E.; Banerji, V.; Barrientos, J.; Bhat, S. A.; Blachly, J.; Broccoli, A.; Call, T.; more...
Leukemia (2024)

Fulltext@MSK | Save

Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

Journal Article

Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
Journal of Hematology & Oncology (2024)

Fulltext@MSK | Save

Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma

Meeting Abstract

Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
Blood (2023)

Fulltext@MSK | Save

First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients

Meeting Abstract

Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
Blood (2023)

Fulltext@MSK | Save

From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: Less is better

Meeting Abstract

Melica, G.; Luna De Abia, A.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Landego, I.; Lin, R. J.; Palomba, M. L.; Parascondola, A.; more...
Blood (2023)

Fulltext@MSK | Save

A phase 2 study of minimal residual disease (MRD)-adapted front line venetoclax and obinutuzumab in fit patients with chronic lymphocytic leukemia (CLL): Effect of obinutuzumab on tumor lysis syndrome (TLS) risk and safety of outpatient venetoclax dose escalation

Meeting Abstract

Roeker, L. E.; Zelenetz, A. D.; Park, J. H.; Derkach, A.; Geyer, M. B.; Islam, P.; Falchi, L.; Palomba, M. L.; Kumar, A.; Salles, G.; more...
Blood (2023)

Fulltext@MSK | Save

Venetoclax in combination with pediatric-inspired chemotherapy in adults with newly diagnosed acute lymphoblastic leukemia: Results of a phase I trial